Evolving Roles of TAVR, SAVR in Aortic Valve Disease w/ Tom C. Nguyen, MD 

The evolving roles of transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in aortic valve disease highlight the importance of long-term data and multidisciplinary collaboration in optimizing patient care.
In a new interview, Tom C. Nguyen, MD, chief medical executive at Miami Cardiac & Vascular Institute, Baptist Health South Florida, discussed the evolving roles of TAVR and SAVR in treating aortic valve disease. Nguyen highlighted that while TAVR has revolutionized the management of high-risk and inoperable patients with aortic stenosis, its long-term durability is still uncertain, particularly in intermediate and low-risk patients. SAVR may remain the preferred option for low-risk patients due to its proven long-term outcomes, especially in younger patients with a life expectancy beyond 5-7 years.
www.hcplive.co...
For more cardiology content, visit www.hcplive.co...
#Cardiology #MedicalNews #Surgery